New COVID Testing Solution Uses Nanopore Tech with AI
Researchers developed a novel platform that couples nanopore technology with artificial intelligence for rapid and accurate COVID testing.
Read MorePosted by Andy Lundin | Oct 26, 2023 | Covid 19 |
Researchers developed a novel platform that couples nanopore technology with artificial intelligence for rapid and accurate COVID testing.
Read MorePosted by Andy Lundin | Oct 20, 2023 | Covid 19 |
3EO Health announced the receipt of an FDA emergency use authorization (EUA) for its SARS-CoV-2 molecular test.
Read MorePosted by Andy Lundin | Oct 20, 2023 | Diagnostic Technologies |
WHO updated its Essential Diagnostics List, a register of in vitro diagnostics supporting countries to make national diagnostic choices.
Read MorePosted by Andy Lundin | Oct 18, 2023 | Company News, Flu & Respiratory Infections |
Evidation has been awarded a contract by BARDA to fund the 2023 Influenza-like Illness (ILI) Detect & Protect Studies.
Read MorePosted by Andy Lundin | Oct 12, 2023 | Infectious Diseases |
Researchers developed a new AI tool that was designed to make predictions about new viral variants before they actually emerge.
Read More